Sign In
Buy ARVN
$7.70
-0.300 (-3.75%)
At Close: Jun 03, 2026
Arvinas Holding Company (ARVN) Gets a Buy Rating from H.C. Wainwright
11:18am, Wednesday, 29'th Apr 2020
H.C. Wainwright analyst
Andrew Fein
reiterated a
Buy
rating on Arvinas Holding Company (
ARVN
–
Research Report
) today and set a price target of
$60.00
. The company’s shares closed last Tuesday
U.S. RESEARCH ROUNDUP- Hormel Foods, Tyson Foods, Zebra Technologies
07:49am, Wednesday, 29'th Apr 2020
Wall Street securities analysts revised their ratings and price targets on several
U.S.-listed companies, including Hormel Foods, Tyson Foods and Zebra Technologies on Wednesday.
HIGHLIGHTS
Recap: Arvinas Q1 Earnings
01:37pm, Tuesday, 28'th Apr 2020
Shares of Arvinas (NASDAQ:ARVN) rose 1.5% after the company reported Q1 results.Quarterly Results Earnings per share were down 21.74% over the past year to ($0.56), which beat the estimate of ($0.60).
Arvinas, Inc. (ARVN) Reports Q1 Loss, Tops Revenue Estimates
12:35pm, Tuesday, 28'th Apr 2020
Arvinas, Inc. (ARVN) delivered earnings and revenue surprises of 5.08% and 20.46%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Arvinas, Inc. (ARVN) Reports Q1 Loss, Tops Revenue Estimates
12:35pm, Tuesday, 28'th Apr 2020
Arvinas, Inc. (ARVN) delivered earnings and revenue surprises of 5.08% and 20.46%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
BRIEF-Arvinas Reports Q1 Loss Per Share Of $0.56
11:48am, Tuesday, 28'th Apr 2020
Arvinas Inc:
Arvinas Reports First Quarter 2020 Financial Results and Provides a Corporate Update
11:00am, Tuesday, 28'th Apr 2020
NEW HAVEN, Conn., April 28, 2020 -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation,.
Arvinas Reports First Quarter 2020 Financial Results and Provides a Corporate Update
11:00am, Tuesday, 28'th Apr 2020
NEW HAVEN, Conn., April 28, 2020 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs...
The Daily Biotech Pulse: Immunic To Develop COVID Treatment, Gilead Strikes IO Partnership
11:51am, Wednesday, 22'nd Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 21) * Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) * Ar
Arvinas (NASDAQ:ARVN) Raised to Strong-Buy at BidaskClub
07:46am, Wednesday, 22'nd Apr 2020
Arvinas (NASDAQ:ARVN) was upgraded by investment analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a research report issued on Wednesday, BidAskClub reports. Several other
The Daily Biotech Pulse: Immunic To Develop COVID Treatment, Gilead Strikes IO Partnership
12:00am, Wednesday, 22'nd Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs April 21)
Alnylam Pharmaceuticals,...
The Daily Biotech Pulse: Applied DNA Begins Validating COVID-19 Test, Cara's Positive Readout, Novan Explores Strategic Alternatives
12:19pm, Tuesday, 21'st Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs April 20) * Abbott Laboratories (NYSE: ABT) * Acceleron Phar
Arvinas Inc (NASDAQ:ARVN) Shares Purchased by Geode Capital Management LLC
10:02am, Tuesday, 21'st Apr 2020
Geode Capital Management LLC lifted its stake in Arvinas Inc (NASDAQ:ARVN) by 40.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 254,212 shar
The Daily Biotech Pulse: Applied DNA Begins Validating COVID-19 Test, Cara's Positive Readout, Novan Explores Strategic Alternatives
12:00am, Tuesday, 21'st Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs April 20)
Abbott Laboratories (NYSE...
Nuveen Asset Management LLC Has $8.93 Million Holdings in Arvinas Inc (NASDAQ:ARVN)
11:06am, Sunday, 19'th Apr 2020
Nuveen Asset Management LLC lifted its stake in shares of Arvinas Inc (NASDAQ:ARVN) by 20.3% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor o
